Group 2 innate lymphoid cells promote airway hyperresponsiveness through production of VEGFA - 04/05/18
This study was supported by the US National Institutes of Health (grant nos. R01AG057782, K22AI116728, R21AI116121), the Albany Medical College (start-up funds to Q.Y.), and the University of California–Davis Pulmonary, Critical Care, and Sleep Division (start-up funds to A.H.), and the National Key Clinical Specialist Construction Program of China (grant no. 2012-649). |
|
Disclosure of potential conflict of interest: X. Shen's institutions received grants from the US National Institutes of Health (grant nos. R01AG057782, K22AI116728), the Albany Medical College (start-up funds), the National Key Clinical Specialist Construction Program of China (grant no. 2012-649) for this work. M. Pasha's, K. Hidde's, A. Khan's, M. Liang's, and Q. Yang's institution received a grant from the US National Institutes of Health (grant nos. R01AG057782, K22AI116728) and the Albany Medical College (start-up funds) for this work. A. Haczku's institution received a grant from the US National Institutes of Health (grant nos. R21AI116121) and the University of California–Davis Pulmonary, Critical Care, and Sleep Division (start-up funds) for this work. W. Guan's and Y. Ding's institutions received a grant from the National Key Clinical Specialist Construction Program of China (grant no. 2012-649) for this work. |
Vol 141 - N° 5
P. 1929 - mai 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?